Efficacy and safety of apremilast in patients with moderate plaque psoriasis (UNVEIL phase 4 study)

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2017
This article has no abstract
Epistemonikos ID: 5164268c345e630a05fc77e4ef9e13c72297a4d5
First added on: Feb 08, 2025